Popular Articles

Trio Of Signals Converge To Induce Liver And Pancreas Cell Development
Understanding the molecular signals that guide early cells in the embryo to develop into different organs provides insight into ways that tissues regenerate and how stem cells can be used for new therapies. With regenerated cells, researchers hope to one day fill the acute shortage in pancreatic and liver tissue available for transplantation in cases of type I diabetes and acute liver failure.
buy viagra
Elan And Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations In Brain Tissue And Cerebrospinal Fluid
Elan Corporation, plc (NYSE: ELN) and Transition Therapeutics Inc. (TSX: TTH, NASDAQ: TTHI) today presented Phase 1 data demonstrating that treatment with ELND005 (scyllo-inositol formerly known as AZD-103), achieves desired concentrations in human brain tissue and cerebrospinal fluid when given orally. Preclinical data also were presented showing that ELND005 administration is associated with preservation of choline acetyltransferase (ChAT), reflecting preservation of nerve cells that are critical to memory function in the brain. ELND005 is an orally-administered drug candidate in Phase 2 trials for the treatment of mild to moderate Alzheimer"s disease. These results were presented at the 2009 Alzheimer"s Association International Conference on Alzheimer"s Disease (ICAD 2009) in Vienna, Austria.
News of the day
A New Government-Run Plan Would Impose Significant Financial Losses On California Hospitals
Many California hospitals would face substantial net losses if there were a large scale shift of individuals with private coverage to a government-run plan that reimburses providers at Medicare rates or Medicare rates plus 10 percent, according to a new hospital-by-hospital analysis released today by America"s Health Insurance Plans (AHIP), based on data from California"s Office of Statewide Health Planning and Development (OSHPD).
Public Health

Psychology Textbook: Translating Science-Based Treatments Into Clinical Settings

Academic Press, a division of Elsevier, would like to announce the publication of a new title in psychology; Evidence-Based Addiction Treatment by Peter Miller, PhD. The growing emphasis on accountability and cost effectiveness in the field of addictions treatment is leading to major changes in standards of care. Inconsistent practices based solely on clinical intuition rather than hard scientific evidence of treatment efficacy are rapidly becoming unacceptable. Translating science-based treatments into clinical settings is now an important priority. Evidence-Based Addiction Treatment provides a state-of-the-art compilation of assessment and treatment practices with proven effectiveness. This graduate level textbook for clinical psychology students and psychiatry residents covers evidence-based practices for the assessment and treatment of addiction, and discusses the treatments that work through explicit case examples and contributions by well-known researchers on addiction treatment. Miller gives students the simple ways to evaluate treatment effectiveness, and offers an accompanying web-site with exam questions for students and instructors. ISBN: 9780123743480 PAGES: 488 PUB DATE: June 2009 Leah Ackerson Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):